Gradual Vs. Rapid Buprenorphine Detoxification - 2

National Institutes of Health (NIH)

Status and phase: Completed; Phase 1

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000220

NIDA-06969-2

R01-06969-2

Details and patient eligibility

About

The purpose of this study is to determine an optimal detoxification dose reduction schedule with buprenorphine.

Sex: All

Ages: 33 to 43 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.